I really admire his approach to investing which is laser focused on the science but also on ensuring effective and efficient management and capital allocation. He was right on Shire and saw the potential in its hemophilia treatment and its low valuation. Also very smart investment in Biocryst which will probably have a high multiple return.
Dr. Denner what is your opinion on the newly redomiciled autologous skin company Avita Therapeutics? It seems like a long term company investment like you speak of in this interview. Thanks, Alex.
I really admire his approach to investing which is laser focused on the science but also on ensuring effective and efficient management and capital allocation. He was right on Shire and saw the potential in its hemophilia treatment and its low valuation. Also very smart investment in Biocryst which will probably have a high multiple return.
Dr. Denner what is your opinion on the newly redomiciled autologous skin company Avita Therapeutics? It seems like a long term company investment like you speak of in this interview. Thanks, Alex.
Vaxart